Loading...
NASDAQ: COO
The Cooper Companies, Inc.
Healthcare · Medical - Instruments & Supplies
●S&P 500 since 2016
Market Cap
$13.86B
52w High
$89.83
52w Low
$61.78
P/E
34.81
Volume
97.97K
Outstanding Shares
195.11M
Company profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
CEOAlbert G. White
SectorHealthcare
IndustryMedical - Instruments & Supplies
Employees16,000
IPO dateJan 21, 1983
Valuation
Forward P/E—
EV/EBITDA15.81
Enterprise value$16.66B
Stock splits
Feb 20, 20244:1
Nov 25, 20022:1
Sep 22, 19951:3
Sep 26, 198311:10
Profitability & growth
Revenue growth6.16%
Gross margin64.24%▼8.95%vs FY2024
Operating margin17.19%▼7.89%vs FY2024
ROE4.55%▼6.24%vs FY2024
Analyst consensus
RatingBuy
Target price$93.86▲32.11%
15
Buy
8
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Jun 4, 2026
View
EPS
Actual vs estimate by quarter
Q3FY25
ActualEst.
$1.10
$1.07
Q4FY25
ActualEst.
$1.15
$1.11
Q1'26
ActualEst.
$1.10
$1.03
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3FY25
ActualEst.
$1.06B
$1.06B
Q4FY25
ActualEst.
$1.07B
$1.06B
Q1'26
ActualEst.
$1.02B
$1.02B
Q1FY26
Next Est.
—